TD Cowen analyst Brendan Smith downgraded Ginkgo Bioworks Holdings Inc (NYSE: DNA) from Buy to Hold with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades